To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min One of the Bay Area's most ...
The high-profile obesity drug developer priced the biotech sector’s biggest offering in years and will use the proceeds to ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results